Stocks and Investing Stocks and Investing
Thu, March 30, 2023
Wed, March 29, 2023

Ed Arce Maintained (VERA) at Strong Buy with Decreased Target to $11 on, Mar 29th, 2023


Published on 2024-10-28 02:28:59 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Vera Therapeutics, Inc." (VERA) at Strong Buy with Decreased Target from $15 to $11 on, Mar 29th, 2023.

Ed has made no other calls on VERA in the last 4 months.



There are 2 other peers that have a rating on VERA. Out of the 2 peers that are also analyzing VERA, all agree with Ed's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Downgraded from Buy to Hold and Held Target at $8 on, Wednesday, January 4th, 2023
  • Maury Raycroft of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, January 4th, 2023
Contributing Sources